Internal Medicine, Infectious Disease · Long Beach, CA
NPI
1770502650
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1040 Elm Ave Ste 200
Long Beach, CA, 90813
Phone (562) 624-4999
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
395 services
Medicare patients, 2024
139
Average age 63
Drug cost, 2024
$8.0M
9,416 prescriptions
Company payments, 2025
$1,251
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marcia Alcouloumre Senteno was code 99214 (office e&m - established), 366 times for 135 patients. In total Marcia Alcouloumre Senteno billed 395 services in 6 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-08-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 366 | 135 | $70.90 | $26K |
| 99213 Office E&M - Established | Facility | 18 | 13 | $44.02 | $792 |
By year: 2022 $23K for 320 services; 2023 $25K for 349 services; 2024 $27K for 395 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marcia Alcouloumre Senteno prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 643 prescriptions and refills. In total Marcia Alcouloumre Senteno wrote 9,416 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 643 | 643 | 75 | $2.5M |
| Atorvastatin Calcium Generic | 525 | 660 | 73 | $1,960 |
| Amlodipine Besylate Generic | 304 | 394 | 44 | $777 |
| Rosuvastatin Calcium Generic | 303 | 409 | 50 | $1,956 |
| Dovato Dolutegravir Sodium/Lamivudine | 296 | 305 | 37 | $877K |
| Descovy Emtricitabine/Tenofov Alafenam | 258 | 258 | 27 | $544K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 257 | 264 | 41 | $8,559 |
| Tivicay Dolutegravir Sodium | 238 | 238 | 24 | $629K |
| Tamsulosin Hcl Generic | 232 | 262 | 35 | $1,064 |
| Gabapentin Generic | 189 | 208 | 31 | $2,327 |
| Testosterone Generic | 180 | 184 | 30 | $23K |
| Acyclovir Generic | 176 | 179 | 28 | $1,081 |
| Benazepril Hcl Generic | 170 | 231 | 21 | $839 |
| Zolpidem Tartrate Generic | 159 | 159 | 23 | $393 |
| Lisinopril Generic | 157 | 215 | 25 | $585 |
Brand drugs: 3,107 claims; generic drugs: 6,290 claims; opioid claims: 285.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marcia Alcouloumre Senteno $1,251 ($1,251 in general payments such as food, travel and fees) from 8 companies. The largest payer was Gilead Sciences, Inc. with $579.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.